AMERICAN CENTURY COMPANIES INC
Position in HRMY — Harmony Biosciences Holdings, Inc.
CIK 748054
KANSAS CITY, MO
Position in HRMY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$92,463,631
+$33,497,568 QoQ
Shares Held
2,539,512
+20.6% QoQ
Ownership
4.36%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#4
of 319 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HRMY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMERICAN CENTURY COMPANIES INC holds $3,568,452,939 across 178 Biotechnology names. HRMY ranks #7 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,853,956 | $558,096,374 | |
| 2 | ASND |
Ascendis Pharma A/S
|
1,400,575 | $373,561,364 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
580,901 | $288,550,953 | |
| 4 | ARGX |
Argenx SE
|
173,193 | $160,683,269 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
1,947,076 | $154,383,656 | |
| 6 | EXEL |
Exelixis, Inc.
|
1,791,664 | $97,484,438 | |
| 7 | HRMY |
Harmony Biosciences Holdings, Inc.
This page
|
2,539,512 | $92,463,631 | |
| 8 | GPCR |
Structure Therapeutics Inc.
|
1,682,179 | $90,282,546 |
All Filings in HRMY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $92,463,631 | 2,539,512 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $58,966,063 | 2,105,179 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $68,915,366 | 1,841,672 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $46,013,211 | 1,669,565 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $47,444,872 | 1,501,420 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $42,774,840 | 1,288,787 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $37,940,603 | 1,102,604 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $34,258,560 | 856,464 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $20,561,941 | 681,536 | Shares | Defined | 2024-08-07 | |
| 2024-03-31 | $14,889,237 | 443,396 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $6,667,333 | 206,419 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $6,737,806 | 205,609 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $16,646,277 | 473,040 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $20,074,558 | 614,841 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $35,995,838 | 653,282 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $31,617,080 | 713,865 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $31,990,486 | 655,946 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $27,550,884 | 566,308 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $20,289,135 | 475,824 | Shares | Defined | 2022-02-07 | |
| 2021-09-30 | $7,237,125 | 188,811 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $5,328,158 | 188,741 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $4,992,046 | 151,091 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $4,285,546 | 118,549 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $3,431,086 | 101,212 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||